Home
Conditions
Lymphatic Diseases

Clinical trial condition

Lymphatic Diseases

Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.

8,984 public trials 1,831 recruiting studies

Refine in advanced search Browse all conditions

Lymphatic Diseases trial results

Completed

Safety and Efficacy of 90Y Zevalin in Nonmyeloablative Transplantation for Lymphoid Malignancies

NCT00048737

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +16 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Screening for Coronary Artery Disease After Mediastinal Irradiation

NCT01271127

Conditions: Arterial Occlusive Diseases, Arteriosclerosis, Cardiovascular Diseases, +16 more
Locations: Leiden University Medical Center Leiden, South Holland, Netherlands

View Trial Details

Completed

Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Acute Lymphoblastic Leukemia

NCT00002700

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Algemeen Ziekenhuis Middelheim Antwerp, Belgium

A.Z. St. Jan Bruges, Belgium

C.H.U. Saint-Pierre Brussels, Belgium

Hopital Universitaire Erasme Brussels, Belgium

View all 44 locations

View Trial Details

Completed

Safety and Immunogenicity of Chiron's Investigational H. Pylori Vaccine in Healthy Adults

NCT00613665

Conditions: Digestive System Diseases, Digestive System Neoplasms, Duodenal Diseases, +20 more
Locations: Universitaetsklinikum Charité Berlin, Germany

View Trial Details

Completed

Validation of the MoistureMeterD in Local Edema by Histamine

NCT01833156

Conditions: Hemic and Lymphatic Diseases, Lymphatic Diseases, Lymphedema
Locations: Expert Center for Lymphovascular Medicine Nij Smellinghe Hospital Drachten, Provincie Friesland, Netherlands

View Trial Details

Completed

Study of ABT-263 When Administered in Combination With Either Fludarabine/Cyclophosphamide/Rituximab or Bendamustine/Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

NCT00868413

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations: Site Reference ID/Investigator# 17841 La Jolla, California, United States

Site Reference ID/Investigator# 25899 Stanford, California, United States

Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States

Site Reference ID/Investigator# 21621 Columbus, Ohio, United States

View Trial Details

Completed

Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia or Advanced Lymphoblastic Non-Hodgkin's Lymphoma

NCT01230983

Conditions: Cardiac Toxicity, Cardiotoxicity, Cardiovascular Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Rituximab Plus Interleukin-2 in Treating Patients With Hematologic Cancer

NCT00010192

Conditions: B-cell Adult Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +82 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Long Term Follow-up of Persistent Pain, Sensory Disturbances and Lymphedema After Breast Cancer Treatment

NCT01543711

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +20 more
Locations: Rigshospitalet, Copenhagen University Hospital Copenhagen, Denmark

View Trial Details

Completed

Bortezomib in Treating Young Patients With Refractory or Recurrent Leukemia

NCT00077467

Conditions: Blast Crisis, Blastic Phase Chronic Myelogenous Leukemia, Bone Marrow Diseases, +24 more
Locations: COG Phase I Consortium Arcadia, California, United States

View Trial Details

Lymphatic Diseases

Lymphatic Diseases trial results

Related conditions